PMC:7029759 / 6455-6669 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"172","span":{"begin":130,"end":131},"obj":"Gene"},{"id":"174","span":{"begin":96,"end":107},"obj":"Species"}],"attributes":[{"id":"A172","pred":"tao:has_database_id","subj":"172","obj":"Gene:43740568"},{"id":"A174","pred":"tao:has_database_id","subj":"174","obj":"Tax:11118"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"today.\n\nTreatment strategies against 2019-nCoV\n\nDeveloping neutralizing antibodies to 2019-nCoV\nCoronavirus entry starts with the S protein binding to a target receptor on the cell surface, where after fusion is me"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T146","span":{"begin":72,"end":82},"obj":"GO:0042571"},{"id":"T145","span":{"begin":86,"end":95},"obj":"SP_7"},{"id":"T144","span":{"begin":96,"end":107},"obj":"NCBITaxon:11118"},{"id":"T143","span":{"begin":130,"end":139},"obj":"PG_1"},{"id":"T142","span":{"begin":176,"end":188},"obj":"GO:0009986"}],"text":"today.\n\nTreatment strategies against 2019-nCoV\n\nDeveloping neutralizing antibodies to 2019-nCoV\nCoronavirus entry starts with the S protein binding to a target receptor on the cell surface, where after fusion is me"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T13","span":{"begin":132,"end":139},"obj":"Body_part"},{"id":"T14","span":{"begin":176,"end":188},"obj":"Body_part"},{"id":"T15","span":{"begin":176,"end":180},"obj":"Body_part"}],"attributes":[{"id":"A13","pred":"fma_id","subj":"T13","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A14","pred":"fma_id","subj":"T14","obj":"http://purl.org/sig/ont/fma/fma67653"},{"id":"A15","pred":"fma_id","subj":"T15","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"today.\n\nTreatment strategies against 2019-nCoV\n\nDeveloping neutralizing antibodies to 2019-nCoV\nCoronavirus entry starts with the S protein binding to a target receptor on the cell surface, where after fusion is me"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T53","span":{"begin":151,"end":152},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T54","span":{"begin":176,"end":180},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"today.\n\nTreatment strategies against 2019-nCoV\n\nDeveloping neutralizing antibodies to 2019-nCoV\nCoronavirus entry starts with the S protein binding to a target receptor on the cell surface, where after fusion is me"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T12","span":{"begin":132,"end":139},"obj":"Chemical"}],"attributes":[{"id":"A12","pred":"chebi_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"today.\n\nTreatment strategies against 2019-nCoV\n\nDeveloping neutralizing antibodies to 2019-nCoV\nCoronavirus entry starts with the S protein binding to a target receptor on the cell surface, where after fusion is me"}

{"project":"LitCovid-sentences","denotations":[{"id":"T42","span":{"begin":8,"end":46},"obj":"Sentence"},{"id":"T43","span":{"begin":48,"end":95},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"today.\n\nTreatment strategies against 2019-nCoV\n\nDeveloping neutralizing antibodies to 2019-nCoV\nCoronavirus entry starts with the S protein binding to a target receptor on the cell surface, where after fusion is me"}